News Buzz: Arca Biopharma, Royal Caribbean Cruises, Celldex Therapeutics, Penn West Petroleum

Lakeway, TX -- (SBWIRE) -- 03/15/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Arca Biopharma Inc(NASDAQ:ABIO) shares soared 38.70% to $3.19. The company, on Mar. 8, announced that Dr. Michael Bristow, President and Chief Executive Officer, will present "The Changing Paradigms in Drug Development" at conference session "Joint Symposium of the Heart Failure Society and the American College of Cardiology II: Heart.

Additionally, the company announced a 6-for-1 reverse split of its common stock. The reverse stock split became effective on March 4, 2013 at 5:01 p.m. Eastern Time, and ARCA’s common stock will continue trading on The NASDAQ Capital Market, on a split-adjusted basis, when the market opens on Tuesday, March 5, 2013.

How Should Investors Trade ABIO The Recent Movement? Find Out Here

Royal Caribbean Cruises Ltd.(NYSE:RCL) shares gained 2.57% and closed at $34.38. The company, on Mar. 8, said that 108 people fell sick with a gastrointestinal illness believed to be a norovirus on its Vision of the Seas ship, which docked in Port Everglades, Florida, at the end of an 11-day trip. The outbreak was the latest black eye for the cruise industry, trying to regain its sea legs after several high-profile mishaps.

Is RCL Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares increased 2.45% and closed at $12.12 in yesterday’s session. The company, on Mar. 7, posted a fourth quarter loss of $16.8 million, or 27 cents per share, compared with a loss of $12.7 million, or 29 cents per share, in the same quarter a year earlier. Revenue jumped 50 percent to $3.6 million from $2.4 million. Analysts expected a loss of 25 cents per share on $2.5 million in revenue.

Is CLDX a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Penn West Petroleum Ltd (USA) (NYSE:PWE) shares gained 2.41% to $11.05. The company, on Mar. 14, announced that it has filed with Canadian securities regulatory authorities its 2012 disclosure documents. Included in the Canadian filings were Penn West's audited consolidated financial statements, related Management's Discussion and Analysis, and its Annual Information Form for the year ended December 31, 2012.

How Should Investors Trade PWE After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.